Introduction to Tirzepatide & Semaglutide
Both Tirzepatide and Semaglutide are effective treatments for type 2 diabetes. Both GLP-1 receptor antagonists are effective in controlling blood sugar and promoting weight loss. As with any medication, there are side effects. This article compares “Tirzepatide Vs Semaglutide side effects” to help patients, healthcare providers, and other people make informed decisions.
Tirzepatide
Tirzepatide acts as a dual GIP and GLP-1 receptor agonist. It works by simulating the actions of incretins, which increase insulin secretion as a response to food, thus helping to control blood glucose levels.
Semaglutide
Semaglutide works as a GLP-1 receptor antagonist, enhancing the release of insulin and suppressing glucagon. The drug is also known for its ability to help patients lose weight. This makes it a good choice for people with obesity and type-2 diabetes.
Mechanism of action
It is essential to understand how Tirzepatide and its side effects work in order to fully appreciate the therapeutic value of this drug.
Tirzepatide
Tirzepatide has a unique action because it targets both GIP- and GLP-1-receptors.
GIP Receptors Activation GIP (glucose-dependent insulinotropic peptide) is a hormone that stimulates the secretion of insulin in response to food intake.
Tirzepatide works by activating GIP receptors. This increases the body’s secretion of insulin, particularly after meals.
GLP-1 receptor activity: GLP-1 or glucagon-like peptide-1 is a hormone that stimulates insulin secretion. It also reduces glucagon release (which lowers the production of hepatic glycogen), promotes fullness, and slows stomach emptying.
Tirzepatide, which mimics GLP-1 and lowers blood glucose levels, also supports weight loss.
Semaglutide
Semaglutide mimics the GLP-1 natural hormone and targets GLP-1 receptors.
Semaglutide can increase insulin secretion, in a glucose-dependent way. It does this by activating GLP-1 on beta cells.
It increases insulin release in response to elevated blood sugar, thus reducing the risk of hypoglycemia.
Semaglutide can help reduce blood sugar spikes after meals by reducing the rate of stomach emptying.
Glucagon Suppression: Semaglutide inhibits glucagon, a hormone that increases blood glucose by stimulating the hepatic production of sugar. Lower glucagon leads to a decrease in glucose production from the liver.
Semaglutide helps reduce food intake and increases the feeling of being full.
Semaglutide Vs Tirzepatide Side Effects
Both medications can manage blood sugar levels, promote weight loss, and reduce insulin resistance. But they do come with side effects that patients must be aware of. Here, we’ll compare the side effects of Tirzepatide with Semaglutide to gain insight into the potential impact.
Common side effects
Some of the common side effects of Tirzepatide and Semaglutide are as follows:
- Nausea: Nausea is a common side effect of Tirzepatide and Semaglutide. This occurs especially during the first few weeks of treatment.
- Vomiting: Vomiting occurs, though it tends to reduce over time.
- Diarrhea: Gastrointestinal disorders like diarrhea are very common.
- Constipation: Semaglutide causes constipation for some patients, but not all.
- Abdominal Discomfort: Another common side effect is abdominal pain.
Serious side Effects
Tirzepatide
- Tirzepatide is associated with a small but real risk of pancreatitis.
- Hypoglycemia can occur, particularly when taken with other antidiabetic medication.
- Allergic reactions: Even though rare, severe allergic reaction can occur.
Semaglutide
- Semaglutide may also cause pancreatitis.
- There are reports that some patients’ kidney function is deteriorating.
- The risk of hypoglycemia increases when combined with other glucose-lowering medications.
- Retinopathy can worsen in some patients with pre-existing diabetes retinopathy.
Rare side effects
Tirzepatide
- Tirzepatide appears to be associated with thyroid cancers C-cells in animal studies. However, the association has not been proven in humans.
- There have been several reports of gallbladder issues.
Semaglutide
- Like Tirzepatide Semaglutide also showed a risk for thyroid C cell tumors in studies on animals.
- Gallbladder Disease includes cholelithiasis.
Comparative Table of Side Effects
| Side effects | Tirzepatide | Semaglutide |
| Nausea | Common | Common |
| Vomiting | Common | Common |
| Diarrhea | Common | Common |
| Constipation | Less Common | Common |
| Abdominal Pain | Common | Common |
| Decreased Appetite | Common | Less Common |
| Pancreatitis | Rare | Rare |
| Hypoglycemia | Increased risk with other medications | Increased risk with other medications |
| Kidney Problems | Not commonly reported | Rare |
| Retinopathy | Not commonly reported | Rare |
| Thyroid Tumors | Potential risk (animal studies) | Potential risk (animal studies) |
| Gallbladder Issues | Rare | Rare |
Conclusion
Both medications share similar side effects with some minor differences. Semaglutide may cause more constipation while Tirzepatide tends to be associated with reduced appetite. Both medications are associated with a possible but unconfirmed risk of thyroid tumors and gallbladder disorders.
In the end, choosing between Tirzepatide vs. Semaglutide depends on a patient’s medical history, tolerance for side effects, and overall treatment goal. To determine the best therapy, it is vital to consult a healthcare provider.
Read more about health and other categories at Guest Writers.
